Elite Pharmaceuticals Inc (ELTP)

[WeeZuhl]

It is beyond moot, it is factually untrue.

It is a moot point. No pharmaceutical in their right mind would ever proceed in a key clinical trial prior to receiving a FDA approved protocol. Since the pharmaceutical is seeking USA Commercial approval for marketing the decision is very simple to wait for a FDA approved Protocol before proceeding with the trial.

My point was not about the FDA approval process, which I agree is moot. My point is Dianne Will. She took a very reasonable question from a shareholder and, instead of answering it directly, she gave a non-answer that is demonstrably false.

ELTP never announced FDA response, only that Phase 3 dosing had begun. Mocha Jet's question re: FDA response to End of Phase 2 meeting is a legitimate issue of due diligence. She can say yes, no, or "I can't say". But instead she says something that does not answer the question and is provably wrong.

Disrespectful. Typical.